Cypress Asset Management Inc. TX Makes New $3.83 Million Investment in Danaher Co. (NYSE:DHR)

Cypress Asset Management Inc. TX acquired a new position in Danaher Co. (NYSE:DHR) in the fourth quarter, Holdings Channel reports. The fund acquired 16,567 shares of the conglomerate’s stock, valued at approximately $3,833,000.

A number of other institutional investors have also added to or reduced their stakes in the company. BKM Wealth Management LLC purchased a new position in Danaher in the fourth quarter valued at about $27,000. Wetzel Investment Advisors Inc. purchased a new stake in shares of Danaher during the 4th quarter valued at approximately $29,000. Rakuten Securities Inc. purchased a new stake in shares of Danaher during the 4th quarter valued at approximately $36,000. Financial Connections Group Inc. purchased a new stake in shares of Danaher during the 4th quarter valued at approximately $41,000. Finally, Frazier Financial Advisors LLC purchased a new stake in shares of Danaher during the 4th quarter valued at approximately $44,000. 79.05% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently commented on the stock. Robert W. Baird upped their price target on shares of Danaher from $259.00 to $271.00 and gave the company an “outperform” rating in a research note on Wednesday, April 24th. KeyCorp upped their target price on shares of Danaher from $260.00 to $290.00 and gave the stock an “overweight” rating in a report on Thursday, February 1st. Barclays upped their target price on shares of Danaher from $260.00 to $270.00 and gave the stock an “equal weight” rating in a report on Wednesday, April 24th. StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Wednesday, January 31st. Finally, TD Cowen upped their target price on shares of Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a report on Wednesday, April 24th. Six equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and an average price target of $267.31.

Danaher Trading Down 2.2 %

DHR traded down $5.79 during trading on Thursday, hitting $261.40. 2,900,718 shares of the stock traded hands, compared to its average volume of 2,699,828. The firm has a market capitalization of $193.62 billion, a P/E ratio of 45.31, a price-to-earnings-growth ratio of 4.08 and a beta of 0.83. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.85 and a quick ratio of 1.51. The firm has a 50-day moving average of $249.54 and a 200 day moving average of $238.04. Danaher Co. has a 12-month low of $182.09 and a 12-month high of $268.98.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 EPS for the quarter, topping the consensus estimate of $1.72 by $0.20. Danaher had a net margin of 16.78% and a return on equity of 11.43%. The firm had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.62 billion. During the same period last year, the company posted $2.36 EPS. The company’s quarterly revenue was down 2.6% compared to the same quarter last year. Equities research analysts anticipate that Danaher Co. will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be given a $0.27 dividend. The ex-dividend date is Friday, June 28th. This represents a $1.08 annualized dividend and a dividend yield of 0.41%. Danaher’s dividend payout ratio is 18.31%.

Insider Transactions at Danaher

In other news, CEO Rainer Blair sold 9,005 shares of the firm’s stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $265.00, for a total value of $2,386,325.00. Following the completion of the sale, the chief executive officer now directly owns 106,990 shares of the company’s stock, valued at approximately $28,352,350. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other Danaher news, SVP Daniel Raskas sold 23,757 shares of the firm’s stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $252.00, for a total transaction of $5,986,764.00. Following the completion of the sale, the senior vice president now directly owns 38,102 shares in the company, valued at approximately $9,601,704. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Rainer Blair sold 9,005 shares of the firm’s stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $265.00, for a total transaction of $2,386,325.00. Following the sale, the chief executive officer now owns 106,990 shares of the company’s stock, valued at $28,352,350. The disclosure for this sale can be found here. In the last ninety days, insiders sold 172,540 shares of company stock valued at $43,523,481. Company insiders own 11.10% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.